Exicure (XCUR) Stock Forecast, Price Target & Predictions
XCUR Stock Forecast
Exicure stock forecast is as follows: an average price target of $12.00 (represents a 415.02% upside from XCUR’s last price of $2.33) and
XCUR Price Target
Exicure Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jan 26, 2022 | Keay Nakae | Chardan Capital | $12.00 | $4.94 | 142.72% | 415.02% |
The latest Exicure stock forecast, released on Jan 26, 2022 by Keay Nakae from Chardan Capital, set a price target of $12.00, which represents a 142.72% increase from the stock price at the time of the forecast ($4.94), and a 415.02% increase from XCUR last price ($2.33).
Exicure Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | - |
| Avg Price Target | - | - | - |
| Last Closing Price | $2.33 | $2.33 | $2.33 |
| Upside/Downside | -100.00% | -100.00% | -100.00% |
In the current month, the average price target of Exicure stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Exicure's last price of $2.33. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.
Exicure Financial Forecast
Exicure Revenue Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | Jun 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | $500.00K | - | - | $2.47M | $21.77M | $2.02M | - | $2.56M | $3.68 | $-3.68M | $79.00K | $997.00K | $140.00K | $2.44M | $4.85M | $9.18M | $310.00K | $527.00K | $434.00K | $25.00K | $57.00K | $19.00K |
| Avg Forecast | - | - | $500.00K | - | - | - | $3.90M | $3.90M | $4.10M | $4.30M | $3.50M | $6.99M | $1.55M | $1.64M | $3.09M | $2.37M | $1.73M | $1.43M | $100.00K | $250.00K | $300.00K | $100.00K | $70.15K | $16.76K |
| High Forecast | - | - | $500.00K | - | - | - | $3.90M | $3.90M | $4.10M | $4.30M | $3.50M | $6.99M | $1.55M | $1.64M | $3.09M | $2.37M | $1.73M | $1.43M | $100.00K | $250.00K | $300.00K | $100.00K | $84.18K | $20.12K |
| Low Forecast | - | - | $500.00K | - | - | - | $3.90M | $3.90M | $4.10M | $4.30M | $3.50M | $6.99M | $1.55M | $1.64M | $3.09M | $2.37M | $1.73M | $1.43M | $100.00K | $250.00K | $300.00K | $100.00K | $56.12K | $13.41K |
| # Analysts | - | - | - | - | - | - | - | 1 | - | - | - | - | - | - | - | - | 9 | 9 | 13 | 13 | 13 | 13 | 15 | 20 |
| Surprise % | - | - | 1.00% | - | - | - | 5.58% | 0.52% | - | 0.60% | 0.00% | -0.53% | 0.05% | 0.61% | 0.05% | 1.03% | 2.80% | 6.41% | 3.10% | 2.11% | 1.45% | 0.25% | 0.81% | 1.13% |
Exicure's average Quarter revenue forecast for Jun 24 based on 0 analysts is -, with a low forecast of -, and a high forecast of -. XCUR's average Quarter revenue forecast represents a -100.00% decrease compared to the company's last Quarter revenue of $500.00K (Mar 24).
Exicure EBITDA Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | Jun 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - | - | 1 | - | - | - | - | - | - | - | - | 9 | 9 | 13 | 13 | 13 | 13 | 15 | 20 |
| EBITDA | - | - | $-829.00K | - | $-3.32M | $-5.76M | $19.04M | $-4.74M | - | $-7.28M | $460.94K | $-23.54M | $-13.37M | $-11.64M | $-11.83M | $-8.12M | $-4.12M | $1.43M | $-9.57M | $-5.27M | $-4.93M | $-5.02M | $-5.06M | $-6.57M |
| Avg Forecast | - | - | $-1.93K | - | - | - | $-15.02K | $-15.02K | $-15.79K | $-1.74M | $-1.41M | $-23.54M | $-12.48M | $-9.70M | $-1.25M | $-7.22M | $-5.67M | $-578.85K | $-40.38K | $-5.80M | $-5.31M | $-5.02M | $-6.01M | $-5.69M |
| High Forecast | - | - | $-1.93K | - | - | - | $-15.02K | $-15.02K | $-15.79K | $-1.74M | $-1.41M | $-18.83M | $-9.99M | $-7.76M | $-1.25M | $-5.77M | $-4.54M | $-578.85K | $-40.38K | $-4.64M | $-4.25M | $-4.01M | $-4.81M | $-4.55M |
| Low Forecast | - | - | $-1.93K | - | - | - | $-15.02K | $-15.02K | $-15.79K | $-1.74M | $-1.41M | $-28.25M | $-14.98M | $-11.64M | $-1.25M | $-8.66M | $-6.80M | $-578.85K | $-40.38K | $-6.96M | $-6.37M | $-6.02M | $-7.22M | $-6.83M |
| Surprise % | - | - | 430.65% | - | - | - | -1268.16% | 315.44% | - | 4.19% | -0.33% | 1.00% | 1.07% | 1.20% | 9.48% | 1.13% | 0.73% | -2.46% | 237.07% | 0.91% | 0.93% | 1.00% | 0.84% | 1.15% |
0 analysts predict XCUR's average Quarter EBITDA for Jun 23 to be -, with a high of - and a low of -. This is -100.00% lower than Exicure's previous annual EBITDA (Dec 22) of $19.04M.
Exicure Net Income Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | Jun 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - | - | 1 | - | - | - | - | - | - | - | - | 9 | 9 | 13 | 13 | 13 | 13 | 15 | 20 |
| Net Income | - | - | $-829.00K | - | $-5.26M | $-7.47M | $18.40M | $-5.12M | - | $-611.01K | $-65.79 | $-23.53M | $-14.27M | $-12.48M | $-12.69M | $-8.82M | $-4.31M | $1.15M | $-9.98M | $-5.82M | $-5.22M | $-5.29M | $-5.32M | $-6.83M |
| Avg Forecast | $13.33M | $11.61M | $13.64M | $18.07M | $12.01M | $10.05M | $-8.22M | $-38.93M | $-10.38M | $-17.71M | $-35.42M | $-23.53M | $-13.32M | $-10.40M | $-26.31M | $-7.84M | $-5.93M | $2.19M | $-22.14M | $-6.40M | $-5.62M | $-5.29M | $-6.32M | $-5.91M |
| High Forecast | $13.33M | $11.61M | $13.64M | $18.07M | $12.01M | $10.05M | $-8.22M | $-38.93M | $-10.38M | $-17.71M | $-35.42M | $-18.82M | $-10.65M | $-8.32M | $-26.31M | $-6.27M | $-4.74M | $2.62M | $-22.14M | $-5.12M | $-4.50M | $-4.23M | $-5.06M | $-4.73M |
| Low Forecast | $13.33M | $11.61M | $13.64M | $18.07M | $12.01M | $10.05M | $-8.22M | $-38.93M | $-10.38M | $-17.71M | $-35.42M | $-28.24M | $-15.98M | $-12.48M | $-26.31M | $-9.41M | $-7.11M | $1.75M | $-22.14M | $-7.68M | $-6.75M | $-6.34M | $-7.59M | $-7.10M |
| Surprise % | - | - | -0.06% | - | -0.44% | -0.74% | -2.24% | 0.13% | - | 0.03% | 0.00% | 1.00% | 1.07% | 1.20% | 0.48% | 1.13% | 0.73% | 0.53% | 0.45% | 0.91% | 0.93% | 1.00% | 0.84% | 1.15% |
Exicure's average Quarter net income forecast for Jun 23 is $10.05M, with a range of $10.05M to $10.05M. XCUR's average Quarter net income forecast represents a -45.35% decrease compared to the company's last Quarter net income of $18.40M (Dec 22).
Exicure SG&A Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | Jun 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - | - | 1 | - | - | - | - | - | - | - | - | 9 | 9 | 13 | 13 | 13 | 13 | 15 | 20 |
| SG&A | - | - | $1.34M | - | $2.40M | $4.72M | $2.11M | $2.42M | - | $3.16M | $10.14 | $2.95M | $3.10M | $2.89M | $2.73M | $2.42M | $2.23M | $2.57M | $2.15M | $2.23M | $1.99M | $2.21M | $1.92M | $1.99M |
| Avg Forecast | - | - | $-1.85M | - | - | - | $-14.43M | $-14.43M | $-15.17M | $40.21M | $32.73M | $2.95M | $14.52M | $15.37M | $28.89M | $2.15M | $16.21M | $13.40M | $935.02K | $2.34M | $2.81M | $935.02K | $655.94K | $156.75K |
| High Forecast | - | - | $-1.85M | - | - | - | $-14.43M | $-14.43M | $-15.17M | $40.21M | $32.73M | $3.54M | $14.52M | $15.37M | $28.89M | $2.59M | $16.21M | $13.40M | $935.02K | $2.34M | $2.81M | $935.02K | $787.12K | $188.09K |
| Low Forecast | - | - | $-1.85M | - | - | - | $-14.43M | $-14.43M | $-15.17M | $40.21M | $32.73M | $2.36M | $14.52M | $15.37M | $28.89M | $1.72M | $16.21M | $13.40M | $935.02K | $2.34M | $2.81M | $935.02K | $524.75K | $125.39K |
| Surprise % | - | - | -0.72% | - | - | - | -0.15% | -0.17% | - | 0.08% | 0.00% | 1.00% | 0.21% | 0.19% | 0.09% | 1.13% | 0.14% | 0.19% | 2.30% | 0.95% | 0.71% | 2.36% | 2.93% | 12.68% |
Exicure's average Quarter SG&A projection for Jun 24 is -, based on 0 Wall Street analysts, with a range of - to -. The forecast indicates a -100.00% fall compared to XCUR last annual SG&A of $1.34M (Mar 24).
Exicure EPS Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | Jun 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - | - | 1 | - | - | - | - | - | - | - | - | 9 | 9 | 13 | 13 | 13 | 13 | 15 | 20 |
| EPS | - | - | $-0.10 | - | $-0.00 | $-0.00 | $0.56 | $-1.03 | - | $-0.15 | - | $-8.01 | $-4.86 | $-4.26 | $-4.33 | $-3.03 | $-1.48 | $0.39 | $-3.39 | $-2.70 | $-3.53 | $-3.58 | $-3.85 | $-5.19 |
| Avg Forecast | $1.54 | $1.34 | $1.58 | $2.09 | $1.39 | $1.19 | $-0.95 | $-4.50 | $-1.20 | $-2.10 | $-4.20 | $-2.77 | $-4.20 | $-3.72 | $-3.12 | $-2.77 | $-2.55 | $-2.70 | $-2.63 | $-2.40 | $-3.90 | $-3.60 | $-0.19 | $-0.13 |
| High Forecast | $1.54 | $1.34 | $1.58 | $2.09 | $1.39 | $1.19 | $-0.95 | $-4.50 | $-1.20 | $-2.10 | $-4.20 | $-2.77 | $-4.20 | $-3.72 | $-3.12 | $-2.77 | $-2.55 | $-2.70 | $-2.63 | $-2.40 | $-3.90 | $-3.60 | $-0.15 | $-0.10 |
| Low Forecast | $1.54 | $1.34 | $1.58 | $2.09 | $1.39 | $1.19 | $-0.95 | $-4.50 | $-1.20 | $-2.10 | $-4.20 | $-2.77 | $-4.20 | $-3.72 | $-3.12 | $-2.77 | $-2.55 | $-2.70 | $-2.63 | $-2.40 | $-3.90 | $-3.60 | $-0.23 | $-0.16 |
| Surprise % | - | - | -0.06% | - | -0.00% | -0.00% | -0.59% | 0.23% | - | 0.07% | - | 2.89% | 1.16% | 1.15% | 1.39% | 1.09% | 0.58% | -0.14% | 1.29% | 1.12% | 0.91% | 0.99% | 20.24% | 39.92% |
According to 0 Wall Street analysts, Exicure's projected average Quarter EPS for Jun 23 is $1.19, with a low estimate of $1.19 and a high estimate of $1.19. This represents a 112.91% increase compared to XCUR previous annual EPS of $0.56 (Dec 22).
Exicure Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| PMVP | PMV Pharmaceuticals | $1.51 | $24.75 | 1539.07% | Buy |
| MIST | Milestone Pharmaceuticals | $1.55 | $10.00 | 545.16% | Buy |
| LIFE | aTyr Pharma | $1.90 | $11.00 | 478.95% | Buy |
| XCUR | Exicure | $2.29 | $12.00 | 424.02% | - |
| LUMO | Lumos Pharma | $3.70 | $16.50 | 345.95% | Buy |
| DMAC | DiaMedica Therapeutics | $4.13 | $8.00 | 93.70% | Buy |
| ELYM | Eliem Therapeutics | $7.98 | $13.00 | 62.91% | Buy |
| MCRB | Seres Therapeutics | $1.05 | $1.25 | 19.05% | Buy |
| IKNA | Ikena Oncology | $1.66 | $1.33 | -19.88% | Buy |
XCUR Forecast FAQ
Will Exicure stock go up soon?
According to Wall Street analysts' prediction for XCUR stock, the company can go up by 415.02% (from the last price of $2.33 to the average price target of $12), up by 415.02% based on the highest stock price target, and up by 415.02% based on the lowest stock price target.
Can Exicure stock reach $3?
XCUR's average twelve months analyst stock price target of $12 supports the claim that Exicure can reach $3 in the near future.
What are Exicure's analysts' financial forecasts?
XCUR's analysts financial forecasts for the fiscal year (Dec 2023) are as follows: average revenue is $0 (high $0, low $0), average EBITDA is $0 (high $0, low $0), average net income is $40.13M (high $40.13M, low $40.13M), average SG&A $0 (high $0, low $0), and average EPS is $4.67 (high $4.67, low $4.67).
Did the XCUR's actual financial results beat the analysts' financial forecasts?
Based on Exicure's last annual report (Dec 2022), the company's revenue was $28.83M, beating the average analysts forecast of $16.2M by 77.94%. Apple's EBITDA was $-1.856M, beating the average prediction of $-1.782M by 4.13%. The company's net income was $-2.582M, missing the average estimation of $-75.237M by -96.57%. Apple's SG&A was $10.89M, missing the average forecast of $-3.832M by -384.19%. Lastly, the company's EPS was $-0.56, missing the average prediction of $-8.75 by -93.60%. In terms of the last quarterly report (Mar 2024), Exicure's revenue was $500K, beating the average analysts' forecast of $500K by 0%. The company's EBITDA was $-829K, beating the average prediction of $-1.925K by 42964.94%. Exicure's net income was $-829K, missing the average estimation of $13.64M by -106.08%. The company's SG&A was $1.34M, missing the average forecast of $-1.85M by -172.20%. Lastly, the company's EPS was $-0.0958, missing the average prediction of $1.58 by -106.08%